Recent Quarter Total Invested
$123.55 M
Recent Quarter Institutional Ownership Percentage
222.47%
Total Invested of Last Quarter
$12.68 M
Ownership Percentage of Last Quarter
49.64%
ARCA biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| WESTERN STANDARD LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 16 | $61 | -11.11% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 50 | $192 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 151 | $579 | -14.20% | 0.00% |
| PARALLEL ADVISORS, LLC | 08/08/2024 | 244 | $935 | 0.00% | 0.00% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 275 | $1,000 | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 344 | $1,318 | -88.81% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 07/30/2024 | 2,000 | $7,660 | 100.00% | 0.01% |
| CITADEL ADVISORS LLC | 08/14/2024 | 3,985 | $15,263 | 225.57% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 5,600 | $21,448 | 100.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 7,131 | $27,312 | 100.00% | 0.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 14,988 | $57,404 | 0.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 19,500 | $74,685 | 100.00% | 0.13% |
| NORTHERN TRUST CORP | 08/14/2024 | 20,982 | $80,361 | 0.00% | 0.14% |
| CITADEL ADVISORS LLC | 08/14/2024 | 22,100 | $84,643 | -59.60% | 0.15% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 27,779 | $106,394 | 100.00% | 0.19% |
| ABRDN PLC | 08/09/2024 | 32,461 | $124,326 | 0.00% | 0.22% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 42,502 | $162,783 | 0.00% | 0.29% |
| STATE STREET CORP | 08/14/2024 | 59,707 | $228,678 | 0.00% | 0.41% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 72,484 | $277,614 | 100.00% | 0.50% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 73,099 | $279,969 | 11.26% | 0.50% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 84,676 | $324,309 | 100.00% | 0.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 161,735 | $619,527 | 13.62% | 1.12% |
| BLACKROCK INC. | 08/13/2024 | 247,909 | $949,492 | 7.21% | 1.71% |
| COMMODORE CAPITAL LP | 08/14/2024 | 414,325 | $1.59 M | 100.00% | 2.86% |
| VANGUARD GROUP INC | 08/13/2024 | 453,598 | $1.74 M | 0.00% | 3.13% |
| MORGAN STANLEY | 08/14/2024 | 650,000 | $2.49 M | 100.00% | 4.48% |
| COWEN AND COMPANY, LLC | 08/07/2024 | 700,000 | $2.68 M | 100.00% | 4.83% |
| VR ADVISER, LLC | 08/14/2024 | 866,375 | $3.32 M | 100.00% | 5.97% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 1.00 M | $3.83 M | 100.00% | 6.89% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 1.20 M | $4.60 M | 100.00% | 8.27% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 1.38 M | $5.23 M | 100.00% | 9.53% |
| RTW INVESTMENTS, LP | 08/14/2024 | 1.40 M | $5.36 M | 100.00% | 9.65% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.85 M | $14.73 M | 100.00% | 26.51% |
| CABLE CAR CAPITAL LLC | 08/14/2024 | 4.00 M | $15.32 M | 0.00% | 27.58% |
| PERCEPTIVE ADVISORS LLC | 08/14/2024 | 15.51 M | $59.39 M | 100.00% | 106.90% |
ARCA biopharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ABIO shares?
During the previous two years, 40 institutional investors and hedge funds held shares of ARCA biopharma, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 15.51 M
Cable Car Capital LLC: 4 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 3.85 M
RTW INVESTMENTS, LP: 1.4 M
JANUS HENDERSON GROUP PLC: 1.38 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.2 M
-
What percentage of ARCA biopharma, Inc. stock is owned by institutional investors?
222.47% of ARCA biopharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ABIO ?
Institutional investors have bought a total of 32.31 M shares in the last 24 months. This purchase volume represents approximately $930.43 M in transactions.